Insider buying last 90 days
No open-market insider purchases were filed for DOC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Healthpeak's week centers on strong Q3 2026 results, with FFOA and revenues beating estimates on solid outpatient leasing and senior housing growth, prompting the company to raise its full-year FFOA outlook for the third time in 2026. The Q3 guidance revision put the FFO midpoint at $1.77 with a payout ratio improving to 69%. Commentary points to stabilization and leasing momentum in the Lab segment, with buildings near existing campuses targeted to climb from 41% occupancy toward a 9% to 10% stabilized yield. Separately, a stock offering at Janus Living (JAN) will leave Healthpeak affiliates with majority voting power there.
Shares closed at $20.62, up 1.8%, sitting above both the 50-day average of $19.74 and the 200-day average of $19.20, with the 50-day above the 200-day. The GekkoIndex reads 49.7, placing it in the Neutral zone, down 9.2 over the past five readings. Price remains 20.5% below Gekko Fair Value of $25.95.
The next earnings date falls on 1 February 2027, 83 days out and beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the current windows, though one billionaire holder and one trailblazer holder are noted. Seasonally, the next 20 trading days have averaged a 2% gain over 5 years, rising in 3 of those years. Analyst coverage from 11 firms shows 1 buy and 10 hold ratings, with a consensus target of $22.95.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Healthpeak Properties scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $19.98 is above the 50-day ($19.68) and 200-day ($19.25) averages, and the 50-day is above the 200-day.
See the chart54.9, Neutral
Reading 54.9 is in the Neutral zone.
See the GekkoIndex23.0% below
Price is 23% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 78 days
Next report Feb 1, 2027, 78 days away — outside a typical 20-trading-day hold.
See earnings+1.8% on average
From this point in the calendar, the next 20 trading days averaged +1.8% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Healthpeak Properties closed at $19.98 on Nov 13, 2026, +13.3% over the past year, inside a 52-week range of $15.70 to $22.95.
Use the left and right arrow keys to read daily values.
Put DOC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Healthpeak Properties works as a real estate investment trust, focusing its efforts on properties tied to medical research and healthcare delivery. Rather than spreading across many property types, it concentrates on real estate that supports the science and treatment side of health, acquiring, managing, and developing buildings suited to those specialized uses. This focus on medical and research-oriented facilities is central to how the company is recognized.
As a REIT, Healthpeak generates income primarily through owning and operating these specialized properties, drawing on rental and related revenue from tenants engaged in healthcare and medical research activities. Its portfolio approach centers on holding higher-quality assets within this niche rather than diversifying into unrelated real estate categories.
Healthpeak Properties is included among the constituents of the S&P 500 index. Its shares trade under the ticker DOC.
Healthpeak Properties’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.9, in the Neutral zone, up 3.7 points over five sessions.
Up 3.7 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 23 | +0.1% | +3.4% | ||
| Accumulation | 241 | +0.4% | +0.3% | ||
| Neutral (current zone) | 364 | 0.0% | 0.0% | ||
| Distribution | 24 | −0.3% | +2.8% | ||
| Selling | 3 | Too few readings yet | |||
Average DOC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Healthpeak Properties trades 23.0% below Gekko Fair Value of $25.95, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Healthpeak Properties shares are worth, recalculated every trading day.
$25.95
Gekko Fair Value, Oct 9, 2026
23.0% Undervalued
At the end of Aug 2026 the price was 29.9% below the estimate.
No open-market insider purchases were filed for Healthpeak Properties, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for DOC in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in DOC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Healthpeak Properties has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds DOC.
Healthpeak Properties reports on Feb 1, 2027 (78 days away), and beat the EPS estimate in 4 of its last 8 reports.
Feb 1, 2027
78 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $0.08 est $0.03 | $749.8M est $725.6M | +0.7% |
| May 5, 2026 | $0.28 est $0.05 | $738.8M est $694.6M | +19.7% |
| Feb 2, 2026 | $0.47 est $0.45 | $704.8M est $691.6M | −4.6% |
| Oct 23, 2025 | $0.46 est $0.45 | $705.9M est $685.1M | +0.8% |
| Jul 24, 2025 | $0.46 est $0.46 | $694.3M est $701.7M | −7.6% |
| Apr 24, 2025 | $0.46 est $0.46 | $702.9M est $689.2M | −5.3% |
| Feb 3, 2025 | $0.05 est $0.05 | $698.0M est $698.3M | −2.9% |
| Oct 24, 2024 | $0.05 est $0.05 | $700.4M est $686.1M | −3.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Healthpeak Properties is $22.95, +14.9% from the last close, from 11 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 11 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | UBS | $22 | +10.1% |
| Nov 9 | RBC Capital | $24 | +20.1% |
| Nov 9 | Bank of America Securities | $25 | +25.1% |
| Nov 3 | Morgan Stanley | $22 | +10.1% |
| Nov 3 | Wells Fargo | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Healthpeak Properties averaged +1.8% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.1% | 2 of 5 |
| Next 10 trading days | +1.7% | 4 of 5 |
| Next 15 trading days | +1.7% | 3 of 5 |
| Next 20 trading days | +1.8% | 2 of 5 |
| Next 30 trading days | +2.1% | 2 of 5 |
For scale, DOC’s typical 20-trading-day move in either direction is about 5%.
Healthpeak Properties’s market cap is $13.78B, with a P/E ratio of 53.3 and revenue of $2.95B over the last twelve months.
1 headline about Healthpeak Properties from the past week, newest first, each linking to the publisher.
Healthpeak Properties’s market cap is $13.78B at the Nov 13, 2026 close of $19.98, with 689.5M shares outstanding. The shares trade on a P/E ratio of 53.3.
The consensus analyst 12-month price target for Healthpeak Properties is $22.95, +14.9% from the last close. Of the 11 firms that rated the stock in the last 90 days, 2 rate it a buy, 9 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Healthpeak Properties is undervalued: the Nov 13, 2026 close of $19.98 is 23.0% below Gekko Fair Value of $25.95. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Healthpeak Properties is expected to report on Feb 1, 2027 (78 days away). Analysts expect earnings of $0.04 per share on revenue of $762.2M. Healthpeak Properties beat the earnings estimate in 4 of its last 8 reports, moving 5.6% on average across the report.
Healthpeak Properties’s 52-week high is $22.95 and its 52-week low is $15.70; it closed at $19.98 on Nov 13, 2026, +13.3% over the past year. Over the last five years the shares peaked at $36.85 on Jan 5, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and earnings risk), 2 as mixed (gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.